ZEN Graphene Solutions Announces Initial Phase 2 Cytotoxicity Results for Its Graphene-Based Compound

This release was issued on February 4, 2021 and speaks only as of that date. It has not been updated. For Zentek’s current disclosure, see SEDAR+ and EDGAR.